CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing incidence of ESRD and prevalence of smoking & target diseases
4.1.2. Growing adoption of minimally invasive surgeries
4.1.3. Growth in the ageing population and the associated increase in the prevalence of an
aneurysm
4.1.4. Technological advancements in vascular grafts
4.2. Market Restraints & Challenges
4.2.1. Complications associated with the prosthetic grafts
4.2.2. Product failures and recalls coupled with the high cost of treatment
4.3. Market Opportunities
4.3.1. Huge market opportunities in developing nations
4.3.2. Increase in patient awareness
4.3.3. Development of biosynthetic vascular grafts
CHAPTER 5. GLOBAL VASCULAR GRAFT MARKET – BY INDICATION
5.1. Hemodialysis Access
5.2. Endovascular Aneurysm Repair
5.2.1. Abdominal Aortic Aneurysms Repair
5.2.2. Thoracic Aortic Aneurysm Repair
5.3. Peripheral Vascular Repair
5.4. Others
CHAPTER 6. GLOBAL VASCULAR GRAFT MARKET – BY RAW MATERIAL
6.1. Polyurethane Grafts
6.2. Biosynthetic Grafts
6.3. Polyester Grafts
6.4. EPTFE Grafts
CHAPTER 7. GLOBAL VASCULAR GRAFT MARKET – BY END USER
7.1. Ambulatory Surgical Centers
7.2. Hospitals
7.3. Others
CHAPTER 8. GLOBAL VASCULAR GRAFT MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL VASCULAR GRAFT MARKET - COMPANY PROFILES
9.1. Shanghai Suokang Medical Implants Co. Ltd.
9.2. W.L. Gore & Associates, Inc.
9.3. Medtronic PLC
9.4. Cook Group Incorporated.
9.5. LeMaitre Vascular, Inc.
9.6. Bard Peripheral Vascular Inc.
9.7. Getinge Group
9.8. Terumo Medical Corporation
9.9. Junken Medical Co., Ltd.
9.10. Cardinal Health, Inc.
9.11. B. Braun Melsungen AG
9.12. Endologix, Inc.
CHAPTER 10. GLOBAL VASCULAR GRAFT MARKET - COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
